Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (51-60 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|June 11, 2024
Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage StudyAlison D Marshall, Jake Rance, Gregory J Dore, et al.
Implementation Science : IS|June 9, 2023
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative studyAnna Conway, Alison D Marshall, Sione Crawford, et al.
The Journal of Infectious Diseases|November 27, 2020
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the ClinicSahar Bajis, Tanya L Applegate, Jason Grebely, et al.
Addiction (Abingdon, England)|January 22, 2023
Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated frameworkLise Lafferty, Yumi Sheehan, Amanda Cochrane, et al.
The International Journal on Drug Policy|August 10, 2015
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
Journal of the International AIDS Society|August 8, 2017
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Jason Grebely, Gregory J Dore, Sébastien Morin, et al.
Plos One|July 5, 2013
Sequencing of the Hepatitis C Virus: A Systematic ReviewBrendan Jacka, Francois Lamoury, Peter Simmonds, et al.
The International Journal on Drug Policy|August 28, 2021
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infectionAndreea Adelina Artenie, Matthew Hickman, Peter Vickerman, et al.
The International Journal on Drug Policy|August 10, 2015
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
The International Journal on Drug Policy|September 24, 2021
"That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prisonLise Lafferty, Amanda Cochrane, Yumi Sheehan, et al.
Pageof 37

Showing results (51-60 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|June 11, 2024
Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage StudyAlison D Marshall, Jake Rance, Gregory J Dore, et al.
Implementation Science : IS|June 9, 2023
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative studyAnna Conway, Alison D Marshall, Sione Crawford, et al.
The Journal of Infectious Diseases|November 27, 2020
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the ClinicSahar Bajis, Tanya L Applegate, Jason Grebely, et al.
Addiction (Abingdon, England)|January 22, 2023
Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated frameworkLise Lafferty, Yumi Sheehan, Amanda Cochrane, et al.
The International Journal on Drug Policy|August 10, 2015
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
Journal of the International AIDS Society|August 8, 2017
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Jason Grebely, Gregory J Dore, Sébastien Morin, et al.
Plos One|July 5, 2013
Sequencing of the Hepatitis C Virus: A Systematic ReviewBrendan Jacka, Francois Lamoury, Peter Simmonds, et al.
The International Journal on Drug Policy|August 28, 2021
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infectionAndreea Adelina Artenie, Matthew Hickman, Peter Vickerman, et al.
The International Journal on Drug Policy|August 10, 2015
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
The International Journal on Drug Policy|September 24, 2021
"That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prisonLise Lafferty, Amanda Cochrane, Yumi Sheehan, et al.
Pageof 37